{
  "docId": "019dd923-622c-750b-8b9a-3bcd52c6e583",
  "docSlug": "f06b0b5d2079",
  "documentTitle": "Soleno Therapeutics (SLNO)",
  "authorId": "58_Scorpion_Capital",
  "authorName": "Scorpion Capital",
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2025-08-15 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 353,
  "pageCount": 415,
  "prevPage": 352,
  "nextPage": 354,
  "slideType": "testimonial",
  "function": "illustrate_case",
  "density": "overcrowded",
  "nDataPoints": 0,
  "notes": "The slide uses a Q&A format to highlight expert skepticism.",
  "elementsJson": [
    "headline_text",
    "paragraph",
    "footnote"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b9a-3bcd52c6e583/353",
  "deckHref": "/decks/019dd923-622c-750b-8b9a-3bcd52c6e583",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b9a-3bcd52c6e583.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b9a-3bcd52c6e583#slide-353",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "I don't know how much success they're going to have with insurance covering these medications.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd953-64ce-7561-b2b4-154d78aebeb1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.18,
        "w": 0.86,
        "x": 0.07,
        "y": 0.46
      },
      "kind": "list",
      "text": "Q: “Have you heard anything from your colleagues in endocrinology communities or about enthusiasm about this drug? Are people like, we’ll see? Is there any buzz or chatter about it?”\nA: “I think one person told me about the news of the release of the FDA approval of this medication, but that's really about it.”\nQ: “Do you plan to use it in any of your five patients? Or maybe cautiously try it? Or you’re wait and see?”\nA: “I would probably wait and see at this point. Let’s say, if the hyperphagia really worsens, or maybe if the support system says, hey, we want to try this medication. Obviously, if they already have a baseline, poorly controlled diabetes, it probably wouldn't be the best idea. I would be willing to try it, but with hesitancy.” - Endocrinologist at Massachusetts General Hospital",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "507ddc41-a664-4eee-a2dc-0bd445bc4b96",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.18,
        "w": 0.86,
        "x": 0.07,
        "y": 0.69
      },
      "kind": "list",
      "text": "Q: “Are you aware of what their pricing Vykat?”\nA: “I don’t, but I’m going to assume it’s probably at least $1,000. Right?”\nQ: “$500,000 to $1 million a year.”\nA: “Oh, God.”\nQ: “It’s something like $1,500 to $3,000 per pill per day for a small-molecule tablet.”\nA: “I don’t know how much success they’re going to have with insurance covering these medications.” - Endocrinologist at Massachusetts General Hospital",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bc71bccc-5c67-4a85-a1be-fceece3ce2f7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.86,
        "x": 0.07,
        "y": 0.41
      },
      "kind": "paragraph",
      "text": "Has heard almost no chatter or enthusiasm about Vykat; “wait and see at this point” about using it; wouldn’t use in diabetic patients; may “be willing to try it” at some point “but with hesitancy”",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4d11afd8-c0cb-4b67-968b-7c05886a6264",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.86,
        "x": 0.07,
        "y": 0.64
      },
      "kind": "paragraph",
      "text": "Had no idea of price and assumed maybe $1,000; shocked at actual price; “don’t know how much success they’re going to have with insurance”",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "996e65c1-8b43-404c-9fc2-6b9cde9af6d6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "quote",
      "text": "“Oh, God...I don't know how much success they're going to have with insurance covering these medications”; “I think one person told me about the news of the release of the FDA approval...but that's really about it”; “I would probably wait and see at this point...obviously, if they already have a baseline, poorly controlled diabetes, it probably wouldn't be the best idea. I would be willing to try it, but with hesitancy.” — Endocrinologist at Massachusetts General Hospital",
      "attrs": null,
      "subkind": null,
      "toolName": "Authority citation",
      "toolSlug": "authority-citation",
      "confidence": null,
      "componentId": "019dd953-64ce-7561-b2b4-1a2ab80ff107",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.25,
        "x": 0.07,
        "y": 0.95
      },
      "kind": "source-note",
      "text": "Source: Scorpion Capital consultation calls with experts",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2e24685f-85ef-46a2-8d3b-e555b3127992",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.86,
        "x": 0.07,
        "y": 0.07
      },
      "kind": "title",
      "text": "Endocrinologist #3: Indicated no discussion or buzz about Vykat among endocrinology colleagues Mass General; was unaware of the price and assumed it was around $1,000, then was in disbelief when we shared the figure – “Oh, God...I don't know how much success they're going to have with insurance covering these medications”; “I think one person told me about the news of the release of the FDA approval...but that's really about it”; “I would probably wait and see at this point...obviously, if they already have a baseline, poorly controlled diabetes, it probably wouldn't be the best idea. I would be willing to try it, but with hesitancy.”",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f05ebb67-06c7-4271-8e95-6df8a33ca285",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}